NCT05515146

Brief Summary

The number of tattooed people is increasing and some complications secondary to tattoos suggest that the lymphatic vascular system might be implicated in their pathogenesis. Abnormalities have been described at the level of the lymph nodes draining the tattooed areas but nothing was reported about the lymphatic vessels under tattoos. This is the aim of the present work.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2022

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 15, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 25, 2022

Completed
Last Updated

August 25, 2022

Status Verified

August 1, 2022

Enrollment Period

2 months

First QC Date

August 15, 2022

Last Update Submit

August 24, 2022

Conditions

Keywords

lymphatic vesselsindocyanin greennear infra red fluorescence lymphatic imagingtattoo

Outcome Measures

Primary Outcomes (3)

  • normal or abnormal lympho-vascular drainage

    The following pictures were considered as normal \- lymphatic vessels are well seen and drainage is fast spontaneously

    imagings were performed directly after the injection (duration 3 minutes)

  • normal or abnormal lympho-vascular drainage

    The following pictures were considered as normal \- lymphatic vessels are well seen after stretching and massages of the injected site

    imagings were performed directly after the stretching and massages (duration 3 minutes)

  • normal or abnormal lympho-vascular drainage

    The following pictures were considered as normal \- lymphatic vessels are well seen after 30 minutes of normal activities and direct between the injected site and-towards the first lymph node at the root of the limb

    imagings were performed after a period of normal activities (duration 30 minutes)

Interventions

ICG (0.2 ml from 25mg of ICG diluted by 5.0 ml of aqua ad injectabilia) was injected intradermally at the basis of the tattooed cutaneous area and at one point chosen so that the tracer had to flow under this area directly towards the root of the limb

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

nineteen subjects (nine women and ten men; mean age = 28.6, range 23-39 years) with tattoos at the level, either of the lower limb (n = 11), or of the upper limb (n = 9) Except in 4 cases, tattoos were older than 2 years (mean = 52.5 months).

You may qualify if:

  • presence of one tattoo at the level of one limb
  • written informed consent

You may not qualify if:

  • History of iodine allergy or anaphylactic reactions to insect bites or medication;
  • Hyperthyroidism;
  • Severe cardiac or pulmonary disease;
  • Significant renal failure (creatinine \> 400 μmol/l);
  • Pregnancy;
  • any known disease of the skin (such as psoriasis);
  • any disease known to affect the cutaneous tissues (such as diabetes);
  • any previous operation and/or trauma at the level of tattooed limb;
  • familial history of lower limb edemas:
  • skin infection after the tattoo

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pierre Bourgeois

Paliseul, 6850, Belgium

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof Dr P Bourgeois

Study Record Dates

First Submitted

August 15, 2022

First Posted

August 25, 2022

Study Start

December 1, 2021

Primary Completion

January 31, 2022

Study Completion

January 31, 2022

Last Updated

August 25, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations